Pulse Biosciences Corporate Bonds and Leverage Analysis
| PLSE Stock | USD 19.63 1.84 10.34% |
Pulse Biosciences holds a debt-to-equity ratio of 0.446. At present, Pulse Biosciences' Short Term Debt is projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.80, whereas Short and Long Term Debt Total is forecasted to decline to about 10 M. . Pulse Biosciences' financial risk is the risk to Pulse Biosciences stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Pulse Biosciences' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Pulse Biosciences' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Pulse Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Pulse Biosciences' stakeholders.
For most companies, including Pulse Biosciences, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Pulse Biosciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Pulse Biosciences' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
The current year's Non Current Liabilities Total is expected to grow to about 12.6 M, whereas Total Current Liabilities is forecasted to decline to about 4.4 M. Pulse |
Given the importance of Pulse Biosciences' capital structure, the first step in the capital decision process is for the management of Pulse Biosciences to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Pulse Biosciences to issue bonds at a reasonable cost.
Pulse Biosciences Bond Ratings
Pulse Biosciences financial ratings play a critical role in determining how much Pulse Biosciences have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Pulse Biosciences' borrowing costs.| Piotroski F Score | 4 | Poor | View |
| Beneish M Score | (4.67) | Unlikely Manipulator | View |
Pulse Biosciences Debt to Cash Allocation
Many companies such as Pulse Biosciences, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Pulse Biosciences currently holds 9.14 M in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Pulse Biosciences has a current ratio of 3.08, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Pulse Biosciences' use of debt, we should always consider it together with its cash and equity.Pulse Biosciences Total Assets Over Time
Pulse Biosciences Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Pulse Biosciences uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Pulse Biosciences Debt Ratio | 80.0 |
Pulse Biosciences Corporate Bonds Issued
Most Pulse bonds can be classified according to their maturity, which is the date when Pulse Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Pulse Net Debt
Net Debt |
|
Understaning Pulse Biosciences Use of Financial Leverage
Pulse Biosciences' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Pulse Biosciences' total debt position, including all outstanding debt obligations, and compares it with Pulse Biosciences' equity. Financial leverage can amplify the potential profits to Pulse Biosciences' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Pulse Biosciences is unable to cover its debt costs.
| Last Reported | Projected for Next Year | ||
| Net Debt | -31.7 M | -30.1 M | |
| Long Term Debt | 74.8 M | 78.5 M | |
| Short and Long Term Debt Total | 10.5 M | 10 M | |
| Short Term Debt | 1.2 M | 1.4 M | |
| Short and Long Term Debt | 1.1 M | 744.1 K | |
| Net Debt To EBITDA | 0.96 | 0.91 | |
| Debt To Equity | (33.72) | (32.03) | |
| Interest Debt Per Share | 0.03 | 0.02 | |
| Debt To Assets | 0.76 | 0.80 | |
| Long Term Debt To Capitalization | 0.93 | 0.83 | |
| Total Debt To Capitalization | 0.93 | 0.98 | |
| Debt Equity Ratio | (33.72) | (32.03) | |
| Debt Ratio | 0.76 | 0.80 | |
| Cash Flow To Debt Ratio | (0.64) | (0.67) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| S | SentinelOne | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out the analysis of Pulse Biosciences Fundamentals Over Time. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.